Earlier this month, members of the Parasites Without Borders team traveled from New York, New Jersey, Florida, and Glasgow, Scotland to Seattle, Washington for the ASTMH 71st Annual Meeting at the Seattle Convention Center.
Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection or Vaccination in Pregnancy | Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations | Acute and postacute sequelae associated with SARS-CoV-2 reinfection
Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 | Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection | Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution | Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review | Protection against Omicron from Vaccination and Previous Infection in a Prison System | Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19
Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 | Reinfections with Different SARS-CoV-2 Omicron Subvariants, France (CDC) | In adults with COVID-19, melatonin was assessed for effects on inflammatory markers, clinical signs and symptoms, and mortality | Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season — Chile, 2022 | Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants | Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
For the first time in three years, the American Society of Tropical Medicine & Hygiene (ASTMH) will be holding their Annual Meeting in-person. Thousands of doctors, scientists, researchers, members of academia, nonprofit organizations, and more will gather at the Seattle Convention Center in Seattle, Washington, Sunday, October 30th through Wednesday, November 3rd, for the 71st ASTMH conference.
Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022 | Polio by the Numbers—A Global Perspective | Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector RSV Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV Seropositive Children 12–24 Months | Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022 | Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages